82 related articles for article (PubMed ID: 16927819)
1. [Targeting of nitric oxide-donor and related drugs].
Zhang YH; Tian JD; Peng SX
Yao Xue Xue Bao; 2006 Jun; 41(6):481-6. PubMed ID: 16927819
[No Abstract] [Full Text] [Related]
2. [Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis].
Chen L; Shang J; Wang ZF; Zhang YH; Tian JD
Yao Xue Xue Bao; 2010 Dec; 45(12):1516-22. PubMed ID: 21351491
[TBL] [Abstract][Full Text] [Related]
3. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
[TBL] [Abstract][Full Text] [Related]
4. [Advances in the study of nitric oxide-donating drugs].
Zhang YH; Peng SX
Yao Xue Xue Bao; 2009 Nov; 44(11):1200-10. PubMed ID: 21355319
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-hepatocellular carcinoma activity of novel O
Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of nitric oxide-releasing derivatives of oleanolic acid as inhibitors of HepG2 cell apoptosis.
Chen L; Zhang Y; Kong X; Peng S; Tian J
Bioorg Med Chem Lett; 2007 Jun; 17(11):2979-82. PubMed ID: 17446070
[TBL] [Abstract][Full Text] [Related]
7. A glycosylated nitric oxide donor, beta-Gal-NONOate, and its site-specific antitumor activity.
Chen C; Shi Y; Li S; Qi Q; Gu L; Song J; Wang PG
Arch Pharm (Weinheim); 2006 Jul; 339(7):366-71. PubMed ID: 16783837
[TBL] [Abstract][Full Text] [Related]
8. Oleanolic acid-NO donor-platinum(II) trihybrid molecules: Targeting cytotoxicity on hepatoma cells with combined action mode and good safety.
Fang L; Feng M; Chen F; Liu X; Shen H; Zhao J; Gou S
Bioorg Med Chem; 2016 Oct; 24(19):4611-4619. PubMed ID: 27501909
[TBL] [Abstract][Full Text] [Related]
9. Sialated diazeniumdiolate: a new sialidase-activated nitric oxide donor.
Cai TB; Lu D; Landerholm M; Wang PG
Org Lett; 2004 Nov; 6(23):4203-5. PubMed ID: 15524443
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver.
Fiorucci S; Antonelli E; Morelli A
Dig Liver Dis; 2003 May; 35 Suppl 2():S61-9. PubMed ID: 12846445
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide release from coumarin-7-azomethine derivatives in the presence of thiol.
Kontogiorgis CA; Hadjipavlou-Litina D
Arzneimittelforschung; 2007; 57(3):143-6. PubMed ID: 17469648
[TBL] [Abstract][Full Text] [Related]
12. Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.
Jones M; Inkielewicz I; Medina C; Santos-Martinez MJ; Radomski A; Radomski MW; Lally MN; Moriarty LM; Gaynor J; Carolan CG; Khan D; O'Byrne P; Harmon S; Holland V; Clancy JM; Gilmer JF
J Med Chem; 2009 Nov; 52(21):6588-98. PubMed ID: 19821574
[TBL] [Abstract][Full Text] [Related]
13. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE
Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994
[TBL] [Abstract][Full Text] [Related]
14. Carbon-bound diazeniumdiolates from the reaction of nitric oxide with amidines.
Hrabie JA; Citro ML; Chmurny GN; Keefer LK
J Org Chem; 2005 Sep; 70(19):7647-53. PubMed ID: 16149795
[TBL] [Abstract][Full Text] [Related]
15. Diazeniumdiolated carbamates: a novel class of nitric oxide donors.
Nandurdikar RS; Maciag AE; Cao Z; Keefer LK; Saavedra JE
Bioorg Med Chem; 2012 Mar; 20(6):2025-9. PubMed ID: 22356735
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
Wu D; Cederbaum A
Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of nitric oxide donor into 1,3-dioxyxanthones leads to synergistic anticancer activity.
Liu J; Zhang C; Wang H; Zhang L; Jiang Z; Zhang J; Liu Z; Chen H
Eur J Med Chem; 2018 May; 151():158-172. PubMed ID: 29609121
[TBL] [Abstract][Full Text] [Related]
18. Micelles for delivery of nitric oxide.
Jo YS; van der Vlies AJ; Gantz J; Thacher TN; Antonijevic S; Cavadini S; Demurtas D; Stergiopulos N; Hubbell JA
J Am Chem Soc; 2009 Oct; 131(40):14413-8. PubMed ID: 19764751
[TBL] [Abstract][Full Text] [Related]
19. Combining ursodeoxycholic acid or its NO-releasing derivative NCX-1000 with lipophilic antioxidants better protects mouse hepatocytes against amiodarone toxicity.
Ouazzani-Chahdi A; Elimadi A; Chabli A; Spénard J; Colin P; Haddad PS
Can J Physiol Pharmacol; 2007 Feb; 85(2):233-42. PubMed ID: 17487265
[TBL] [Abstract][Full Text] [Related]
20. N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide.
Rakshit S; Bagchi J; Mandal L; Paul K; Ganguly D; Bhattacharjee S; Ghosh M; Biswas N; Chaudhuri U; Bandyopadhyay S
Apoptosis; 2009 Mar; 14(3):298-308. PubMed ID: 19153832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
